PME announcing a $14m 7 year contract deal with Duke Health,...

  1. 2,791 Posts.
    lightbulb Created with Sketch. 427
    PME announcing a $14m 7 year contract deal with Duke Health, catapulting its share price up 7% to almost its all time high again.
    Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year contract with Duke Health ("Duke"), the largest health system in the state of North Carolina and one of the most respected health providers in North America.
    The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented across all of Duke’s radiology departments and integrated to Duke’s electronic health record (EHR).
    The implementation will span three hospitals and dozens of additional locations across Duke Health, including their flagship 957-bed academic medical center, Duke University Hospital. Planning for the rollout is to commence in Q4 FY19 with the first sites scheduled to be implemented in Q1 FY20.

    In my previous post, I indicated that 'strength begets strength' and Promedicus, via its Visage imaging technology is building more business on top of its well developed credentials. The brand reputation and IP makes PME a global player in its own right that can outbeat the GEs and Panasonics of the world.

    This is why I see Volpara as having the same qualities as PME albeit at an initial stage, having already commanded about 7% of all women who does breast screening in the US. Likewise, Polynovo via its BTM IP is set to be a global leader in burn reconstruction surgery technology. And Dubber (DUB) the first on the cloud call recording system is also recognised by global telecommunication giants and included as part of their Telco managed service offering. They are great stories to hold.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.